Arlington Capital Partners Acquires Majority Stake in Riverpoint Medical

Riverpoint Medical Acquires C.P. Medical Corporation

June 20, 2024

Medical Devices

Riverpoint Medical, a portfolio company of Arlington Capital Partners, has completed the acquisition of C.P. Medical Corporation, a manufacturer of specialty surgical and animal health wound closure products. The add-on transaction expands Riverpoint's wound-closure and specialty surgical capabilities; DC Advisory advised Riverpoint and Arlington while Capstone Partners advised CP Medical.

Arlington Capital Partners Acquires Millstone Medical Outsourcing

January 11, 2022

Medical Devices

Arlington Capital Partners, a Washington, DC-based private equity firm, has acquired Millstone Medical Outsourcing, a Fall River, Massachusetts-based provider of post-manufacturing, quality-critical services and supply chain logistics to medical device and pharmaceutical manufacturers. Selling shareholders included Schooner Capital; Arlington said it will provide strategic and capital support to accelerate Millstone's organic growth and pursue strategic acquisitions.

Arlington Capital Partners Acquires TEAM Technologies

November 26, 2024

Medical Devices

Arlington Capital Partners has acquired TEAM Technologies, a Morristown, Tennessee–headquartered medical device manufacturer and strategic supply‑chain solutions provider, from Clearlake Capital Group for an undisclosed sum. Arlington plans to build on TEAM Tech’s vertically integrated manufacturing footprint and accelerate growth through organic investment and strategic add‑on M&A to strengthen healthcare supply chains and customer capabilities.

Aquiline Capital Partners Takes Majority Stake in SurePoint Technologies

June 2, 2021

Cloud & SaaS

Aquiline Capital Partners has acquired a majority stake in SurePoint Technologies, a cloud provider of practice management and financial software for law firms. Existing investor ParkerGale Capital rolled a portion of its equity and will remain a minority owner; the investment is intended to accelerate product development and platform capabilities for law firm clients.

Great Point Partners Completes Growth Recapitalization of Velentium

September 29, 2021

Medical Devices

Great Point Partners completed a growth recapitalization of Houston-based Velentium, a professional engineering and contract medical device manufacturer. The investment will fund Velentium's expansion initiatives — including tuck-in acquisitions and enhanced engineering and manufacturing capabilities — while preserving the company's quality and culture.

Arlington Capital Partners Makes Majority Investment in Afton Scientific

January 30, 2024

Pharmaceuticals

Arlington Capital Partners has made a majority investment in Afton Scientific, a Charlottesville-based CDMO specializing in sterile injectable drug manufacturing and related lab/packaging services. The partnership will support Afton's capacity growth and expansion of service offerings while founder and CEO Tom Thorpe remains a material shareholder and will continue to lead the company.